Therapy Areas: Inflammatory Diseases
BioPharmX Corporation announces US FDA's waiver of additional dermal carcinogenicity studies of BPX-01
20 July 2018 - Pharmaceutical company BioPharmX Corporation (NYSE American:BPMX) revealed on Thursday that the US Food and Drug Administration has waived its requirement for several years of non-clini...
Longevity Biotech Begins Study to Identify Inflammatory Biomarkers of Parkinson's Disease
19 July 2018 - - Philadelphia, Pennsylvania-based biopharmaceutical company Longevity Biotech, Inc. (LBT) is launching a new clinical study to identify specific immune and inflammatory markers th...
Landos Biopharma Doses First Subjects in Clinical Trial of Investigational IBD Treatment
18 July 2018 - - Blacksburg, Virginia-based clinical-stage biopharmaceutical company Landos Biopharma, Inc. has dosed the first healthy subjects in a phase 1 clinical study of BT-11, a first-in-class,...
Locus Biosciences enhances CRISPR-engineered phage therapeutics technology via acquisition of phage platform
18 July 2018 - Biotechnology company Locus Biosciences Inc revealed on Tuesday the completion of the acquisition of the high-throughput bacteriophage (phage) discovery platform from EpiBiome Inc for a...
Takeda submits new indication application for Entyvio in Japan
18 July 2018 - Takeda Pharmaceutical Co Ltd (TYO: 4502) has submitted an application to the Ministry of Health, Labour and Welfare (MHLW) in Japan for a new indication for Entyvio for the treatment of...
HSS wins USD5.6m grant in support of translational research and major musculoskeletal conditions
17 July 2018 - Academic medical centre company Hospital for Special Surgery (HSS) reported on Monday the receipt of an additional USD5.6m in grant from The Tow Foundation for translational research as...